Please donate here to support this vital work.
Revealing News For a Better World

Health News Articles
Excerpts of key news articles on


Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.


Note: Explore our full index to revealing excerpts of key major media news articles on dozens of engaging topics. And read excerpts from 20 of the most revealing news articles ever published.


Drug company 'hid' suicide link
2007-01-29, BBC News
http://news.bbc.co.uk/1/hi/programmes/panorama/6291773.stm

Secret emails reveal that the UK's biggest drug company distorted trial results of an anti-depressant, covering up a link with suicide in teenagers. GlaxoSmithKline (GSK) attempted to show that Seroxat worked for depressed children despite failed clinical trials. And that GSK-employed ghostwriters influenced 'independent' academics. GSK faces action in the US where bereaved families have joined together to sue the company. As a result, GSK has been forced to open its confidential internal archive. Karen Barth Menzies is a partner in one of the firms representing many of the families. She has examined thousands of the documents which are stored, box upon box, in an apartment in Malibu, California. She said: "Even when they have negative studies that show that this drug Seroxat is going to harm some kids they still spin that study as remarkably effective and safe for children." An email from a public relations executive working for GSK ... said: "Originally we had planned to do extensive media relations surrounding this study until we actually viewed the results. Essentially the study did not really show it was effective in treating adolescent depression, which is not something we want to publicise." Seroxat was banned for under 18s in 2003 after the MHRA revealed that GSK's own studies showed the drug actually trebles the risk of suicidal thoughts and behaviour in depressed children.

Note: For more reliable information on how the drug companies put profits ahead of your health, click here.


Doctor, Musician Join Fight Against Fluoride
2007-01-25, WSMV-TV (Nashville, TN NBC affiliate)
http://www.wsmv.com/health/10845643/detail.html

Fluoride has become a controversial additive to our drinking water. While no one denies it can prevent cavities with topical application, a growing number of people, cities and countries have decided that ingesting unknown quantities of fluoride is a bad idea. One of Tennessee's own top health risk scientists is asking Gov. Phil Bredesen to stop adding fluoride to the water. Dr. Kathy Thiessen makes a living assessing health risks and has worked for the Center for Disease Control and Prevention and the Environmental Protection Agency. “The deliberate exposure to uncontrolled and unmonitored intake of fluoride is unwise at best and probably harmful to a substantial number of people,” Thiessen said. Thiessen joins Tennessee lawmaker and medical doctor Joey Hensley as the most prominent Tennessee voices against fluoride. Chris White is a musician with the band Loft, but his other passion is removing fluoride from Gallatin's water supply. “All parties point to the American Dental Association recommending that mothers stop using fluoridated water for baby formula as an obvious sign that fluoride is obviously not for everyone,” he said.

Note: This article fails to mention a key recent study showing "about 28 percent of the children in the low-fluoride area scored as bright, normal or higher intelligence compared to only 8 percent in the 'high' fluoride area. In the high-fluoride city, 15 percent had scores indicating mental retardation and only 6 percent in the low-fluoride city." For a truly awesome, revealing interview with a BBC producer on the major deceptions around and dangers of fluoride in water, click here. For more on this key topic from Dr. Mercola, click here. And for the top website on the risks and dangers of flouride in water, click here.


Rise and shine: Wake up to an enhanced life
2007-01-25, CNN News
http://www.cnn.com/2007/TECH/science/01/25/ft.newdrugs

A new breed of lifestyle drugs could allow us to choose how much we sleep, boost our memories and even allow us to enjoy ourselves more, without any side effects. Will they unleash human capabilities never seen before or create a dystopian 24-hour society where we are dependent on drugs to regulate our lifestyle and behavior? One drug already available is modafinil, marketed as the vaguely Orwellian-sounding Provigil. It enables those who take it to stay awake and alert for 48 hours. It is a eugeroic that delivers a feeling of wakefulness without the physical or mental jitter. There is already a market for it for those without any medical need - it is developing a cult following among workaholics and students studying for exams. The military is also very interested in eugeroic. Their reliance on amphetamines for lengthy operations have had catastrophic consequences in the past. The "friendly-fire" incidents in Afghanistan in 2002 when U.S. pilots killed Canadian troops was blamed on the "go pills" they had taken. The U.S. Defense Advanced Research Projects Agency (DARPA) tested a compound called CX717 in its quest to find a drug that can create a "metabolically dominant war-fighter of the future" able to function for seven days without sleep. CX717 is an ampakine, a compound that increases the brains computing powers. It re-writes the rules of what it takes to create a memory and just how strong those memories can be. Will cans of soda containing eugeroics or ampakines be as common as caffeine drinks on the shelves of 24-hour stores? The potential is certainly there for a brave new world of personality medication.


Molecule offers cancer hope
2007-01-17, Toronto Star (One of Canada's leading newspapers)
http://www.thestar.com/News/article/171898

In results that "astounded" scientists, an inexpensive molecule known as DCA was shown to shrink lung, breast and brain tumours in both animal and human tissue experiments. The study was published yesterday in the journal Cancer Cell. "I think DCA can be selective for cancer because it attacks a fundamental process of cancer that is unique to cancer cells," said Dr. Evangelos Michelakis, a professor at the Edmonton university's medical school and one of the study's key authors. The molecule appears to repair damaged mitochondria in cancer cells. "When a cell is getting too old or doesn't function properly, the mitochondria are going to induce the cell death," lead study author Sebastien Bonnet said yesterday. Bonnet says DCA – or dichloroacetate – appears to reverse the mitochondrial changes in a wide range of cancers. "One of the really exciting things about this compound is that it might be able to treat many different forms of cancer because all forms of cancer suppress mitochondrial function," Michelakis said. Bonnet says DCA may also provide an effective cancer treatment because its small size allows easy absorption into the body, ensuring it can reach areas that other drugs cannot, such as brain tumours. Because it's been used to combat other ailments ... DCA has been shown to have few toxic effects on the body. Its previous use means it can be immediately tested on humans. Unlike other cancer drugs, DCA did not appear to have any negative effect on normal cells. It could provide an extremely inexpensive cancer therapy because it's not patented. But ... the lack of a patent could lead to an unwillingness on the part of pharmaceutical companies to fund expensive clinical trials.

Note: Even these scientists realize that though this discovery could be a huge benefit to mankind, because the drug companies will lose profits, they almost certainly will not fund studies. Expensive AIDS drugs with promising results, on the other hand, are rushed through the studies to market. For more reliable, verifiable information on how hugely beneficial health advances are shut down to keep profits high, click here and here.


Industry 'paid top cancer expert'
2006-12-08, BBC News
http://news.bbc.co.uk/1/hi/health/6220440.stm

The scientist who first linked smoking to lung cancer was [later] paid by a chemicals firm while investigating cancer risks in the industry. Professor Sir Richard Doll held a consultancy post with US firm Monsanto for more than 20 years. The BBC has seen private letters which show that Sir Richard ... received a US$1,500-a-day consultancy fee from Monsanto in the mid-1980s. During that time he investigated the potential cancer causing properties of the powerful herbicide Agent Orange, made by the company. Sir Richard [argued] that there was no evidence that Agent Orange caused cancer. Professor Lennart Hardell, of the Oncology Department at University Hospital Orebro, Sweden, has also studied the potential hazards posed by Agent Orange. He was one of the scientists whose work was dismissed by Sir Richard. He said: "It's quite OK to have contacts with industry, but you should be fair and say 'well, I'm [working] as a consultant for Monsanto." Further documents obtained by The Guardian newspaper allegedly show that Sir Richard was also paid a Ł15,000 fee by the Chemical Manufacturers Association, and chemicals companies Dow Chemicals and ICI for a review of vinyl chloride, used in plastics, which largely cleared the chemical of any link with cancers apart from liver cancer. Sir Richard's views on the chemical were used by the manufacturers' trade association to defend it for more than a decade.


U.S. signs deal to stockpile anti-bird-flu drug
2006-07-01, San Francisco Chronicle
http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2006/07/01/MNGDMJNKP21.DTL&h...

Federal health authorities have signed a two-year deal to help states buy more than half a billion dollars worth of the antiviral drug Tamiflu as a hedge against a pandemic of deadly avian influenza, but there is a catch: States will have to pay for three-quarters of it. Under terms of the deal negotiated with Roche by the Department of Health and Human Services, the states can order up to 31 million packets of Tamiflu -- each containing a 10-pill course of treatment -- for a total cost of $596 million over the next two years. The Bush administration announced late Friday that it had contracted with Swiss drugmaker Roche Laboratories Inc. to supply Tamiflu for stockpiles in all 50 states. The federal government, meanwhile, plans to build its own centralized stockpile. The plan is to have enough antiviral drug in state and federal warehouses by December 2008 to treat 81 million people. Tamiflu is considered by scientists to be the first line of defense against the H5N1 strain of bird flu. The disease is currently confined primarily to chickens, ducks and some wild waterfowl, but researchers fear it could mutate into a form that spreads easily among humans.

Note: No mention is made here that Donald Rumsfeld has already made millions from sales of Tamiflu, and that he was on the board of the company that developed the drug. Many top researchers also believe there is little chance of avian flu mutating. Why are we spending hundreds of millions of dollars to combat a virus which has not even mutated yet? To verify these and other vital facts, see http://www.WantToKnow.info/avianflu


Experts Defining Mental Disorders Are Linked to Drug Firms
2006-04-20, Washington Post
http://www.washingtonpost.com/wp-dyn/content/article/2006/04/19/AR20060419025...

Every psychiatric expert involved in writing the standard diagnostic criteria for disorders such as depression and schizophrenia has had financial ties to drug companies that sell medications for those illnesses, a new analysis has found. Of the 170 experts in all who contributed to the manual that defines disorders from personality problems to drug addiction, more than half had such ties, including 100 percent of the experts who served on work groups on mood disorders and psychotic disorders. "I don't think the public is aware of how egregious the financial ties are in the field of psychiatry," said Lisa Cosgrove, a clinical psychologist at the University of Massachusetts in Boston. The analysis comes at a time of growing debate over the rising use of medication as the primary or sole treatment for many psychiatric disorders, a trend driven in part by definitions of mental disorders in the psychiatric manual. Cosgrove said she began her research after discovering that five of six panel members studying whether certain premenstrual problems are a psychiatric disorder had ties to Eli Lilly & Co., which was seeking to market its drug Prozac to treat those symptoms. The process of defining such disorders is far from scientific, Cosgrove added: "You would be dismayed at how political the process can be."


The Cutter Incident: How America's First Polio Vaccine Led to a Growing Vaccine Crisis
2006-03-01, Journal of the Royal Society of Medicine
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1383764/

In April 1955 more than 200,000 children in five Western and mid-Western USA states received a polio vaccine in which the process of inactivating the live virus proved to be defective. Within days there were reports of paralysis and within a month the first mass vaccination programme against polio had to be abandoned. The vaccine, manufactured by the California-based family firm of Cutter Laboratories, had caused 40,000 cases of polio, leaving 200 children with varying degrees of paralysis and killing 10. Paul Offit ... sets the 'Cutter incident' in the context of the struggle of medical science against polio. He profiles leading figures, notably Jonas Salk and Albert Sabin. Reviewing failures in the manufacturing and inspection processes, he exonerates Salk from blame and concludes that `the federal government, through its vaccine regulatory agency... was in the best position to avoid the Cutter tragedy'. As Offit observes, 'ironically, the Cutter incident - by creating the perception among scientists and the public that Salk's vaccine was dangerous - led in part to the development of a polio vaccine that was more dangerous'. [A] court ruling that Cutter was liable to pay compensation to those damaged by its polio vaccine ... opened the floodgates to a wave of litigation. As a result, 'vaccines were among the first medical products almost eliminated by lawsuits'. The National Vaccine Injury Compensation Program was introduced in 1986 to protect vaccine manufacturers from litigation.

Note: Explore an eye-opening article titled "15 Things You Don’t Know About Polio" which shows how the public has been greatly deceived. For more along these lines, see concise summaries of deeply revealing vaccine controversy news articles from reliable major media sources.


Remember Anthrax?
2005-11-02, Newsweek
http://msnbc.msn.com/id/9900947/site/newsweek

Just as President George W. Bush is launching an ambitious plan to guard against an avian flu pandemic, an administration program to prepare for a potential anthrax attack is running into new and unexpected hurdles. VaxGen Inc., a California biotech firm that last year was awarded an $877.5 million contract to supply a newly invented, and so far unlicensed, anthrax vaccine, acknowledged this week that it won't begin to start deliveries to the federal government until the latter part of next year -- six months later than it originally intended. For months, investigators on both sides of the aisle have expressed concerns that the administration may have invested too big a chunk of the nation's biodefenses in one obscure and relatively untested company. Last year's decision by HHS to award the contract to the little-known VaxGen is being scrutinized by at least two congressional committees. The company's product will have to pass more large-scale tests proving its safety and effectiveness on people before it is fully licensed by the Food and Drug Administration for use on humans, and company officials say they do not expect it to be fully licensed at least until 2007. A New York Times report last December noted that...the company had faced lawsuits filed by investors who claimed VaxGen misinformed them about an AIDS vaccine that the company had heavily promoted but which later failed to work.

Note: For more on how greed and corruption in the pharmaceutical industry affects your health and wallet, see our Health Information Center.


AIDS Drug Maker to Pay $704M in Settlement
2005-10-17, ABC/Associated Press
http://abcnews.go.com/Business/wireStory?id=1223871

Serono Laboratories agreed Monday to pay $704 million and plead guilty to federal conspiracy charges that it increased the market for the AIDS drug Serostim by offering kickbacks to doctors and manipulating a test for AIDS patients. Eighty-five percent of prescriptions written for Serostim, accounting for roughly $615 million in sales, were unnecessary. The cost of many of those prescriptions, $21,000 for 12 weeks of treatment, was paid by Medicaid, the joint federal-state health program for the poor, and other government insurance plans. Serono offered doctors free trips to the south of France in return for agreeing to write up to 30 new prescriptions for Serostim. The company also conspired to introduce a test for AIDS wasting, despite not having FDA approval. The test diagnosed AIDS wasting even without weight loss. Monday's settlement is the latest in a series of whistleblower claims that have resulted in more than $3 billion in payments from drug companies in recent years.

Note: For lots more on this vital topic: http://www.WantToKnow.info/healthcoverup


Going (Down) by the Book
2005-09-17, New York Times
http://www.nytimes.com/2005/09/17/opinion/17tierney.html?ex=1284609600&en=7a8...

When the Federal Emergency Management Agency's paperwork slowed the evacuation of patients from the airport, Acadian's frustrated medics waited with empty helicopters. "At one point I had 10 helicopters on the ground waiting to go," said Marc Creswell, an Acadian medic, "but FEMA kept stonewalling us with paperwork. Meanwhile, every 30 or 40 minutes someone was dying." The company sent in outside doctors and nurses. FEMA rejected the help because the doctors and nurses weren't certified members of a National Disaster Medical Team. "When the doctors asked why they couldn't help these critically ill people lying there unattended," Mr. Creswell recalled, "the FEMA people kept saying, 'You're not federalized.' "


Merck's infant vaccine stirs new controversy
2005-03-08, Newsday/Los Angeles Times
http://www.nynewsday.com/news/health/ny-usglan084168623mar08,0,3713664.story

Merck & Co. continued to supply infant vaccine containing a mercury preservative for two years after declaring that it had eliminated the chemical. Thimerosal, which is nearly 50 percent ethyl mercury, has largely been eliminated from most routine childhood vaccines, although it is present in most flu shots. More than 4,200 parents have filed claims in the federal Vaccine Injury Compensation Program, alleging that their children suffered autism or other neurological disorders from mercury in their shots.


AIDS drug therapy connected to death
2004-12-15, Houston Chronicle/Associated Press
http://www.chron.com/disp/story.mpl/nation/2949734.html

Joyce Ann Hafford died without ever holding the son she had tried to save from contracting AIDS by taking an experimental drug regimen administered by government-funded researchers during her pregnancy. But even before her stunned family could grieve, the 33-year-old's death was reverberating among the government's top scientists in Washington. They quickly realized the drugs the HIV-positive woman from Memphis, Tenn., was taking likely caused the liver failure that killed her. Hafford's family members say they were never told NIH had concluded that the experimental drug regimen likely caused her death until the Associated Press gave them copies of NIH's internal case documents this month. They were left to believe Hafford had died from AIDS complications. "They tried to make it sound like she was just sick. They never connected it to the drug," said Rubbie King, Hafford's sister. NIH officials acknowledge that experimental drugs, most likely nevirapine, caused her death. The study during which Hafford died recently led researchers to conclude that nevirapine poses risks when taken over time by certain pregnant women. The family says Hafford seemed unaware of the liver risks. They even kept the bottle of nevirapine showing it had no safety warnings.

Note: If you want to understand just how corrupt and deceitful medical research doctors can be, read the stunning article on this case at this link. This article mentions the little-known fact that "a majority of HIV-positive tests, when retested, come back indeterminate or negative. In many cases, different results emerge from the same blood tested in different labs."


The Truth About the Drug Companies (Book Review)
2004-07-15, New York Review of Books
http://www.nybooks.com/articles/17244

The combined profits for the ten drug companies in the Fortune 500 ($35.9 billion) were more than the profits for all the other 490 businesses put together ($33.7 billion). Over the past two decades the pharmaceutical industry has moved very far from its original high purpose of discovering and producing useful new drugs. Now primarily a marketing machine to sell drugs of dubious benefit, this industry uses its wealth and power to co-opt every institution that might stand in its way, including the US Congress, the FDA, academic medical centers, and the medical profession itself. The great majority of "new" drugs are not new at all but merely variations of older drugs already on the market. Of the 78 drugs approved by the FDA in 2002, only 17 contained new active ingredients, and only seven of these were classified by the FDA as improvements over older drugs. [The] market would collapse virtually overnight if the FDA made approval of new drugs contingent on their being better in some important way than older drugs already on the market. Many medical schools and teaching hospitals set up "technology transfer" offices to ... capitalize on faculty discoveries. Medical school faculty entered into ... lucrative financial arrangements with drug companies, as did their parent institutions. One of the results has been a growing pro-industry bias in medical research—exactly where such bias doesn't belong. The industry ... fought the state of Maine all the way to the US Supreme Court, which in 2003 upheld Maine's right to bargain with drug companies for lower prices. This industry is taking us for a ride, and there will be no real reform without an aroused and determined public to make it happen.

Note: The above book and book review was written by Dr. Marcia Angell, former editor in chief of the prestigious The New England Journal of Medicine. For more reliable information on the health cover-up, click here.


The mysterious lab off New York's shore
2004-04-02, CNN News
http://articles.cnn.com/2004-04-02/entertainment/lab.257_1_plum-island-lab-ge...

Oops. That's the word that comes to mind when reading Michael Carroll's thoroughly nerve-wracking book, "Lab 257: The Disturbing Story of the Government's Secret Germ Laboratory" ... about the federal germ facility on Plum Island. The island [is] home to some of the deadliest microbes festering on the planet. According to Carroll's book, the island -- and laboratory -- are also home to slipshod construction, poor safeguards, and lax security. "Lab 257" claims errors at the facility caused Lyme disease outbreaks and health problems for the local population -- claims disputed by the U.S. Department of Agriculture, which ran the facility until recently. Carroll [said] that the point of the book was to expose the potential hazards of a poorly run institution; he has nothing against better-run, more secure institutions. "You have to know how things interact, germs, bacteria, etc. You [just] don't need to create millions of them to know how to create them and make them more virulent. Like other government scientific facilities, it's had an aura of mystery: Plum Island earns a mention in "The Silence of the Lambs," and thriller writer Nelson DeMille set a novel there. Much of Carroll's research was done through interviews with nearby residents, as well as documents and reports. While the government was "cooperative at the outset," Carroll said ... he was later denied access to the facility. Carroll isn't the first to offer criticism. In 2002, after a power outage on the island, New York's WABC-TV did a story on whether containment procedures worked; several employees questioned the lab's safety. In 2003, the General Accounting Office listed security problems on the island, partially prompted by a whistleblower, Jim McCoy, who protested the management of a private concern.

Note: At the northernmost tip of Long Island, Plum island sits directly across from the town of Lyme, Conn., famous as the epicenter of the Lyme disease outbreak. For a powerful, multiple award-winning film showing shocking ignorance and even political corruption on the part of the medical community about the Lyme disease epidemic spreading across the US and even around the world, click here. It shows evidence that Lyme may be even the cause of many cases of ALS, Parkinson's, and Alzheimer's disease.


Life-Threatening Food?
2001-05-17, CBS News
http://www.cbsnews.com/stories/2001/05/17/eveningnews/main291992.shtml

Last fall, at a business lunch with co-workers, Grace Booth enjoyed three chicken enchiladas. The food, she recalls, was very good — but then something went very wrong. "I thought, oh my God, what is happening to me? I felt like I was going to die." In the emergency room in nearby Oakland the diagnosis was severe allergic reaction and from here Grace Booth's story reached officials in Washington. At the time the national corn market was in an uproar. Starlink, a gene modified corn not approved for human food, had been found in taco shells and recalls were emptying the shelves of corn products. The fear was possible allergic reactions. At that moment, Booth says, she had no idea that the corn tortillas in her lunch were about to be recalled. In the wake of the recalls more than 50 Americans, including Booth, claimed they had reactions to Starlink corn. That forced the government to launch the first full-scale allergy investigation in the history of biotech food. It has taken months, but the Centers for Disease Control and the Food and Drug Administration have collected food samples and blood from two dozen people whose cases were believed most serious. [Symptoms] "[v]aried from just abdominal pain and diarrhea [or] skin rashes to some patients ... having very severe life-threatening reactions," said Dr. Marc Rothenberg, the allergy chief at Cincinnati Children's Hospital. He is an adviser to the government in the Starlink investigation. Its slow going he says because investigators first had to find the Starlink protein and then invent a blood test.

Note: The date of this article is May 17, 2001, though on the webpage itself a different date is listed. With so many examples of allergic reactions and more to GM foods, why does the FDA continue to insist that these foods are safe? Could it be because many top leaders at the FDA once worked at Monsanto?


OxyContin's Deception Costs Firm $634M
2001-05-10, CBS News/Associated Press
https://www.cbsnews.com/news/oxycontins-deception-costs-firm-634m/

Two days after agreeing to pay states nearly $20 million for falsely marketing OxyContin, the drug's maker, Perdue Pharma, and three current and former executives plead guilty to federal charges. The Stamford, Conn.-based maker of the powerful painkiller, and three of its current and former executives, pleaded guilty Thursday to misleading the public about OxyContin's risk of addiction. Purdue Pharma L.P., its president, top lawyer and former chief medical officer will pay $634.5 million in fines for claiming the drug was less addictive and less subject to abuse than other pain medications, U.S. Attorney John Brownlee said. The plea agreement comes after the company agreed to pay $19.5 million to 26 states and the District of Columbia to settle complaints that it encouraged physicians to overprescribe OxyContin. Even though the company was warned by health professionals, the media and members of its own sales force, "Perdue continued to push a fraudulent marketing campaign that promoted OxyContin as less addictive, less subject to abuse and less likely to cause withdrawal when they knew in fact that that was not true," Brownlee told CBS News correspondent Barry Bagnato. "Doctors are often approached right in their offices by pharmaceutical company sales reps dispensing information about one medication or another," said CBS News medical correspondent Dr. Jon LaPook. "This case is a reminder to doctors not to believe everything they hear."

Note: The family which owns Purdue, maker of OxyContin, is among the 20 richest families in the U.S., thanks largely to sales of Oxycontin, which has resulted in thousands of overdose deaths, according to this article in Forbes. For more, see this revealing article. Then see concise summaries of deeply revealing news articles on pharmaceutical industry corruption and health.


Trade Secrets: A Moyers Report
2001-03-29, PBS
http://www.pbs.org/tradesecrets/program/overview.html

Twenty-three years to the day after he went to work with vinyl chloride and other toxic chemicals at a plant in Lake Charles, Louisiana, Dan Ross died of a rare brain cancer. He was 46 years old, convinced that his job had killed him. His wife, Elaine, sued her husband's former employer and, over the next decade, the process of legal discovery led deeper and deeper into the inner chambers of the chemical industry and its Washington trade association. Hundreds of thousands of pages of documents were unearthed. In TRADE SECRETS: A MOYERS REPORT, journalist Bill Moyers and producer Sherry Jones investigated the Ross archive – secrets the chemical industry never intended the public to see – and discovered a shocking story. The confidential papers reveal the industry's early knowledge of vinyl chloride's dangerous effects, as well as the industry's long silence on the subject. The program also reports a much larger story. Buried in the thousands of pages of documents – minutes from board meetings, reports from industry scientists, internal memoranda – is a never-before-told account of a campaign to limit the regulation of toxic chemicals and any liability for their effects, at the same that the companies work to withhold vital information about risks from workers, the government – and the public. Over the last five decades, more than 75,000 chemicals have been produced, turned into consumer products or released into the environment. Today, every man, woman and child has synthetic chemicals in their bodies. No child is born free of them. Are they safe? Does anyone know?

Note: This article also mentions that even though Moyers never lived near a chemical plant, tests showed that his body contained a chemical soup of 84 industrial chemicals, including 31 different types of PCBs, 13 different dioxins, and pesticides such as DDT. Why are these chemicals so poorly studied and the dangerous effects hidden from us? For lots more from reliable sources on corporate corruption, click here.


Are your mercury fillings safe?
2001-02-13, The Telegraph (One of the UK's leading newspapers)
http://www.telegraph.co.uk/news/health/news/4705442/Are-your-mercury-fillings...

My mouth was open, numb and full of instruments by the time I realised what was happening. Only my eyebrows could register alarm that yet another mercury amalgam filling was being inserted in to my tooth. A question mark, I knew, hung over the use of mercury in the mouth, but the dentist dismissed my fears. "I can't tell you exactly how much mercury is present in amalgam," he announced, glancing fretfully at the clock, "but as part of a compound, it is inert." Afterwards, I soon found out that mercury comprises more than 50 per cent of amalgam. Mercury is one of the most poisonous substances known to man. If amalgam were proposed now as a dental filling, it would not be approved, but it has been around for 150 years. There is also now abundant evidence that the metal leaks out. It vapourises at body temperature, particularly during tooth-brushing, chewing and the consumption of hot drinks - and the vapour is more dangerous than the mercury that occurs naturally in food. Some people are known to be unable to tolerate even small amounts. But that doesn't mean that we should all worry about it; according to BDA spokesman Stephen Challacombe, Professor of Oral Medicine at Guy's, King's and St Thomas's hospitals: "Approximately five per cent of the population would react to contact with mercury, as they do to all heavy metals." White fillings are now, their advocates claim ... just as durable and tight-fitting as amalgam. Finding dentists able to insert them in heavily damaged rear teeth is difficult.

Note: Read a report on a recent scientific study which has shown that having multiple amalgam fillings "significantly contribute to prolonged mercury levels in the body." And explore a revealing history of mercury amalgams used in tooth fillings. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources.


When Good Drugs Do Harm
2001-01-08, Los Angeles Times
http://articles.latimes.com/2001/jan/08/health/he-9609

Adverse drug reactions have reached epidemic proportions, killing more people each year than die on the nation's highways, and doing serious damage to millions more. This problem has taken on special significance recently: The FDA has pulled 10 drugs off the market in the past three years for safety reasons, which is unprecedented in the agency's history. Nearly 20 million patients, almost 10% of the U.S. population, were estimated to have been exposed to these drugs before their removal. Few people, however, are aware that their medications could be harmful, or know how to spot the warning signs and what to do if they suspect there's a problem. Yet a 1998 University of Toronto study found that roughly 100,000 Americans die of adverse drug reactions each year, and 2.1 million more are hospitalized. The FDA received reports of more than 258,000 adverse drug events in 1999, nearly quadruple the 68,000 incidents reported a decade earlier. And FDA officials acknowledge that they're catching only a tiny fraction of these incidents. More new therapies are being sold first in the United States, rather than in Europe and Asia. In the early 1980s, only 2% to 3% of new drugs were introduced in the United States. By 1998, that number climbed to more than 60%, according to FDA officials, largely due to faster approvals by the agency. Aggressive marketing of new drugs can exacerbate the problem by persuading doctors and patients to seek out the latest therapies more quickly. And it's not just newer drugs that can be dangerous.

Note: For deeply revealing reports from reliable major media sources on health issues, click here.


Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

Kindly donate here to support this inspiring work.

Subscribe to our free email list of underreported news.

newsarticles.media is a PEERS empowerment website

"Dedicated to the greatest good of all who share our beautiful world"